The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis

    1. Debra Van Egeren
    2. Madison Stoddard
    3. Alexander Novokhodko
    4. Michael S. Rogers
    5. Diane Joseph-McCarthy
    6. Bruce Zetter
    7. Arijit Chakravarty

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19

    1. Alec A. Schmaier
    2. Gabriel M. Pajares Hurtado
    3. Zachary J. Manickas-Hill
    4. Kelsey D. Sack
    5. Siyu M. Chen
    6. Victoria Bhambhani
    7. Juweria Quadir
    8. Anjali K. Nath
    9. Ai-ris Y. Collier
    10. Debby Ngo
    11. Dan H. Barouch
    12. Nathan I. Shapiro
    13. Robert E. Gerszten
    14. Xu G. Yu
    15. Kevin G. Peters
    16. Robert Flaumenhaft
    17. Samir M. Parikh

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. SPEEDS: A portable serological testing platform for rapid electrochemical detection of SARS-CoV-2 antibodies

    1. Ran Peng
    2. Yueyue Pan
    3. Zhijie Li
    4. Zhen Qin
    5. James M. Rini
    6. Xinyu Liu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Key informant perceptions on wildlife hunting during the first COVID-19 lockdown in India

    1. Uttara Mendiratta
    2. Munib Khanyari
    3. Nandini Velho
    4. Kulbhushansingh Ramesh Suryawanshi
    5. Nirmal Kulkarni

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. The SARS-CoV-2 B.1.351 lineage (VOC β) is outgrowing the B.1.1.7 lineage (VOC α) in some French regions in April 2021

    1. Bénédicte Roquebert
    2. Sabine Trombert-Paolantoni
    3. Stéphanie Haim-Boukobza
    4. Emmanuel Lecorche
    5. Laura Verdurme
    6. Vincent Foulongne
    7. Mircea T. Sofonea
    8. Samuel Alizon

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling study

    1. Alicia Rosello
    2. Rosanna C. Barnard
    3. David R. M. Smith
    4. Stephanie Evans
    5. Fiona Grimm
    6. Nicholas G. Davies
    7. Centre for Mathematical Modelling of Infectious Diseases COVID-19 Modelling Working Group
    8. Sarah R. Deeny
    9. Gwenan M. Knight
    10. W. John Edmunds

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. COVID-19 Vaccine Intentions in the United States—December 2020 to March 2021

    1. Mark É Czeisler
    2. Shantha MW Rajaratnam
    3. Mark E Howard
    4. Charles A Czeisler

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Systematic Review and Meta-analysis on COVID-19 Vaccine Hesitancy

    1. Iman Ahmed Fathalla Aboelsaad
    2. Dina Mohamed Hafez
    3. Abdallah Almaghraby
    4. Shaimaa Abdulaziz Abdulmoneim
    5. Samar Ossama El-ganainy
    6. Noha Alaa Hamdy
    7. Ehsan Akram Deghidy
    8. Ahmed El-Sayed Nour El-Deen
    9. Ehab Mohamed Adel Elrewany
    10. Alaa Hamdy Taha Khalil
    11. Karem Mohamed Salem
    12. Samar Galal kabeel
    13. Yasir Ahmed Mohammed Elhadi
    14. Ramy Shaaban
    15. Amr Alnagar
    16. Eman Ahmad Fadel Elsherbeny
    17. Nagwa Ibrahim Elfeshawy
    18. Mohamed Moustafa Tahoun
    19. Ramy Mohamed Ghazy

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Inhibitor screening using microarray identifies the high capacity of neutralizing antibodies to Spike variants in SARS-CoV-2 infection and vaccination

    1. Xiaomei Zhang
    2. Mei Zheng
    3. Hongye Wang
    4. Haijian Zhou
    5. Te Liang
    6. Jiahui Zhang
    7. Jing Ren
    8. Huoying Peng
    9. Siping Li
    10. Haodong Bian
    11. Chundi Wei
    12. Shangqi Yin
    13. Chaonan He
    14. Ying Han
    15. Minghui Li
    16. Xuexin Hou
    17. Jie Zhang
    18. Liangzhi Xie
    19. Jing Lv
    20. Biao Kan
    21. Yajie Wang
    22. Xiaobo Yu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Single‐dose immunisation with a multimerised SARS‐CoV‐2 receptor binding domain (RBD) induces an enhanced and protective response in mice

    1. Ralf Salzer
    2. Jordan J. Clark
    3. Marina Vaysburd
    4. Veronica T. Chang
    5. Anna Albecka
    6. Leo Kiss
    7. Parul Sharma
    8. Andres Gonzalez Llamazares
    9. Anja Kipar
    10. Julian A. Hiscox
    11. Andrew Owen
    12. A. Radu Aricescu
    13. James P. Stewart
    14. Leo C. James
    15. Jan Löwe

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 1227 of 2361 Older